Effects of a 12-week cardiovascular rehabilitation programme on systemic inflammation and traditional coronary artery disease risk factors in patients with rheumatoid arthritis (CARDIA trial): A randomised controlled trial

Medicine & Life Sciences

• Cardiac Rehabilitation 100%
• Coronary Artery Disease 66%
• Rheumatoid Arthritis 66%
• Randomized Controlled Trials 54%
• Cardiovascular Diseases 49%
• Inflammation 47%
• Exercise 44%
• Standard of Care 22%
• Nova Scotia 16%
• Heart Rate 16%
• Research Ethics 16%
• Cardiorespiratory Fitness 14%
• Rheumatic Diseases 12%
• Primary Prevention 11%
• Ethics 11%
• Publications 9%
• Population 8%
• Interleukin-6 8%
• Tumor Necrosis Factor-alpha 8%
• Health Care Outcome Assessment 7%
• Lipids 7%
• Guidelines 7%
• Blood Pressure 7%
• Education 7%
• Health 5%
• Therapeutics 1%